Cascade counselling and testing. Recommendations of the European Society of Human Genetics
Open Access
- 14 December 2025
- journal article
- policy
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 34 (2) , 171-184
Abstract
Cascade testing (CT) is an effective instrument for identifying an index patient’s relatives at high risk of a heritable condition enabling informed decision-making on preventive interventions and reproductive choice. However, CT remains underutilised and faces barriers. Discussions are ongoing on how to optimise informing family members and testing uptake in a responsible manner. The European Society of Human Genetics (ESHG) contributes to this debate and provides recommendations based on an ethical analysis of when CT is justified, or may be less compelling, considering proportionality and the judicious use of finite resources. ESHG underscores the strong consensus regarding the ‘moral architecture’ of CT in cases of a high risk of serious, avoidable harm. In such cases, a more active approach towards CT is suggested, including a more directive approach in counselling, more active support for the proband, direct contacting, and balancing confidentiality when this is necessary to avoid a high risk of serious harm, taking account of national regulations and jurisdictions. In contrast, more caution is advised in more complex cases where the balance of benefits and harms of CT is less clear, such as when penetrance is low, and actionability or medical treatment is limited. This more cautious approach does not call for directivity, direct contact or the relaxing of medical confidentiality. The focus, then, shifts to cascade counselling, rather than cascade testing. In some cases, CT may not be proportional or appropriate given the balance between benefits and harms, also in view of available resources.Keywords
This publication has 101 references indexed in Scilit:
- Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1/BRCA2 variant? A family cancer clinic evaluationJournal of Genetic Counseling, 2023
- Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1International Journal of Clinical Oncology, 2021
- Between responsibility and desire: Accounts of reproductive decisions from those at risk for or affected by late‐onset neurological diseasesJournal of Genetic Counseling, 2021
- How to inform at‐risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general populationJournal of Genetic Counseling, 2019
- How to inform relatives at risk of hereditary diseases? A mixed‐methods systematic review on patient attitudesJournal of Genetic Counseling, 2019
- Evaluation of Cancer-Based Criteria for Use in MainstreamBRCA1andBRCA2Genetic Testing in Patients With Breast CancerJAMA Network Open, 2019
- The Evolving Concept of Non-directiveness in Genetic Counselling2017
- Changing perspectives on the benefits of newborn screeningMental Retardation and Developmental Disabilities Research Reviews, 2006
- Serious genetic disorders: Can or should they be defined?*American Journal of Medical Genetics, 2002
- Presymptomatic testing for Huntington chorea: Ethical and legal issuesAmerican Journal of Medical Genetics, 1987